http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7914797-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fdaa64756184e715af6cb25ebc318917
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-543
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16234
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16134
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5252
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-145
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-145
filingDate 2006-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2011-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_852d189e595ac1e8e6e3803465cae50d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b12e844e1470fc9c860ca9edee2e0f10
publicationDate 2011-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-7914797-B2
titleOfInvention Influenza vaccine
abstract The present invention relates to influenza vaccines for human and veterinary use. In particular, the present invention provides a vaccine able to effect long term and cross-strain protection by including at least two influenza virus epitopes expressed as a chimeric polypeptide wherein at least one epitope is influenza A virus matrix protein epitope and the second epitope is a haemagglutinin peptide epitope.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11111277-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11739127-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10286062-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10370416-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011027315-A1
priorityDate 2005-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0032228-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9907839-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9823735-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6130082-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0200885-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004223976-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4474757-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004080403-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9426903-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9320846-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395099
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395278
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7048786
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6032
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135770023
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5071
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2130
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10444661
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396158
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411198
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395279

Total number of triples: 53.